Making it easier to make stem cells

Sanford-Burnham researchers identified kinase inhibitors that lower the barrier to producing stem cells in the laboratory—cells important for disease research and drug development

2012-09-25

(Press-News.org) LA JOLLA, Calif., September 25, 2012 – The process researchers use to generate induced pluripotent stem cells (iPSCs)—a special type of stem cell that can be made in the lab from any type of adult cell—is time consuming and inefficient. To speed things up, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) turned to kinase inhibitors. These chemical compounds block the activity of kinases, enzymes responsible for many aspects of cellular communication, survival, and growth. As they outline in a paper published September 25 in Nature Communications, the team found several kinase inhibitors that, when added to starter cells, help generate many more iPSCs than the standard method. This new capability will likely speed up research in many fields, better enabling scientists around the world to study human disease and develop new treatments.

"Generating iPSCs depends on the regulation of communication networks within cells," explained Tariq Rana, Ph.D., program director in Sanford-Burnham's Sanford Children's Health Research Center and senior author of the study. "So, when you start manipulating which genes are turned on or off in cells to create pluripotent stem cells, you are probably activating a large number of kinases. Since many of these active kinases are likely inhibiting the conversion to iPSCs, it made sense to us that adding inhibitors might lower the barrier."

According to Tony Hunter, Ph.D., professor in the Molecular and Cell Biology Laboratory at the Salk Institute for Biological Studies and director of the Salk Institute Cancer Center, "The identification of small molecules that improve the efficiency of generating iPSCs is an important step forward in being able to use these cells therapeutically. Tariq Rana's exciting new work has uncovered a class of protein kinase inhibitors that override the normal barriers to efficient iPSC formation, and these inhibitors should prove useful in generating iPSCs from new sources for experimental and ultimately therapeutic purposes." Hunter, a kinase expert, was not involved in this study.

The promise of iPSCs

At the moment, the only treatment option available to many heart failure patients is a heart transplant. Looking for a better alternative, many researchers are coaxing stem cells into new heart muscle. In Alzheimer's disease, researchers are also interested in stem cells, using them to reproduce a person's own malfunctioning brain cells in a dish, where they can be used to test therapeutic drugs. But where do these stem cells come from? Since the advent of iPSC technology, the answer in many cases is the lab. Like their embryonic cousins, iPSCs can be used to generate just about any cell type—heart, brain, or muscle, to name a few—that can be used to test new therapies or potentially to replace diseased or damaged tissue.

It sounds simple enough: you start with any type of differentiated cell, such as skin cells, add four molecules that reprogram the cells' genomes, and then try to catch those that successfully revert to unspecialized iPSCs. But the process takes a long time and isn't very efficient—you can start with thousands of skin cells and end up with just a few iPSCs.

Inhibiting kinases to make more iPSCs

Zhonghan Li, a graduate student in Rana's laboratory, took on the task of finding kinase inhibitors that might speed up the iPSC-generating process. Scientists in the Conrad Prebys Center for Chemical Genomics, Sanford-Burnham's drug discovery facility, provided Li with a collection of more than 240 chemical compounds that inhibit kinases. Li painstakingly added them one-by-one to his cells and waited to see what happened. Several kinase inhibitors produced many more iPSCs than the untreated cells—in some cases too many iPSCs for the tiny dish housing them. The most potent inhibitors targeted three kinases in particular: AurkA, P38, and IP3K.

Working with the staff in Sanford-Burnham's genomics, bioinformatics, animal modeling, and histology core facilities—valuable resources and expertise available to all Sanford-Burnham scientists and the scientific community at large—Rana and Li further confirmed the specificity of their findings and even nailed down the mechanism behind one inhibitor's beneficial actions.

"We found that manipulating the activity of these kinases can substantially increase cellular reprogramming efficiency," Rana said. "But what's more, we've also provided new insights into the molecular mechanism of reprogramming and revealed new functions for these kinases. We hope these findings will encourage further efforts to screen for small molecules that might prove useful in iPSC-based therapies."

INFORMATION:

Note to members of the media: Please contact Heather Buschman at hbuschman@sanfordburnham.org to schedule on-site, phone, or Skype interviews with Tariq Rana, Ph.D. Images are also available upon request.

About Sanford-Burnham Medical Research Institute

Sanford-Burnham Medical Research Institute is dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. The Institute consistently ranks among the top five organizations worldwide for its scientific impact in the fields of biology and biochemistry (defined by citations per publication) and currently ranks third in the nation in NIH funding among all laboratory-based research institutes. Sanford-Burnham utilizes a unique, collaborative approach to medical research and has established major research programs in cancer, neurodegeneration, diabetes, and infectious, inflammatory, and childhood diseases. The Institute is especially known for its world-class capabilities in stem cell research and drug discovery technologies. Sanford-Burnham is a U.S.-based, non-profit public benefit corporation, with operations in San Diego (La Jolla), California and Orlando (Lake Nona), Florida. For more information, news, and events, please visit us at sanfordburnham.org.

[Attachments] See images for this press release:

ELSE PRESS RELEASES FROM THIS DATE:

Impaired protein degradation causes muscle diseases

2012-09-25

When the "fire brigade" arrives too late Impaired protein degradation causes muscle diseases RUB researchers and international colleagues report in Brain New insights into certain muscle diseases, the filaminopathies, are reported by an international research team led by Dr. Rudolf Andre Kley of the RUB's University Hospital Bergmannsheil in the journal Brain. The scientists from the Neuromuscular Centre Ruhrgebiet (headed by Prof. Matthias Vorgerd) at the Neurological University Clinic (Director: Prof. Martin Tegenthoff) cooperated with colleagues from eleven institutes ...

Palliative care experts call for better home care

2012-09-25

Improved home care resources for people with conditions such as dementia, who would prefer to die at home, are key to providing better end of life care and reducing the strain of the UK's ageing population on the NHS, according to researchers at King's College London. A new study, carried out by researchers from the Cicely Saunders Institute at King's and funded by the National Institute for Health Research Health Services &Delivery Research (NIHR HS&DR) Programme, found that 42 per cent of patients with advanced non-malignant conditions reported a preference for home ...

Dr. Yutaka Niihara: Novel therapy helps ease pain and suffering for sickle cell patients

2012-09-25

LOS ANGELES (Sept. 25, 2012) – Chronic, debilitating pain and potential organ failure are what approximately 100,000 sickle cell patients in the United States live with each day. Yutaka Niihara, M.D., M.P.H. - lead investigator at The Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) and co-founder of Emmaus Medical, Inc., an LA BioMed spin-off company - is developing a low-cost, noninvasive treatment that helps provide relief for patients suffering from the debilitating effects of sickle cell disease. Dr. Niihara and his team of investigators ...

Researchers develop new technique for IDing proteins secreted by cells

2012-09-25

Researchers from North Carolina State University have developed a new technique to identify the proteins secreted by a cell. The new approach should help researchers collect precise data on cell biology, which is critical in fields ranging from zoology to cancer research. The work is important because cells communicate by secreting proteins. Some of the proteins act on the cell itself, telling it to grow or multiply, for example. But the proteins can also interact with other cells, influencing them to perform any biological function. Traditionally, scientists who wanted ...

Oscillating microscopic beads could be key to biolab on a chip

2012-09-25

CAMBRIDGE, Mass. -- If you throw a ball underwater, you'll find that the smaller it is, the faster it moves: A larger cross-section greatly increases the water's resistance. Now, a team of MIT researchers has figured out a way to use this basic principle, on a microscopic scale, to carry out biomedical tests that could eventually lead to fast, compact and versatile medical-testing devices. The results, based on work by graduate student Elizabeth Rapoport and assistant professor Geoffrey Beach, of MIT's Department of Materials Science and Engineering (DMSE), are described ...

'The Dust Queen's' research stars in new American Chemical Society video

2012-09-25

WASHINGTON, Sept. 25, 2012 — A new episode in the American Chemical Society's (ACS') popular Prized Science video series features insights into the effects of wind-blown dust on human health and climate from Vicki Grassian, Ph.D. She has jokingly been called "the Dust Queen" and is a noted authority on the tiny particles of sand and dirt, termed mineral dust, that are transported from areas as remote as the Sahara Desert. The video, produced by the ACS, the world's largest scientific society, is available at www.acs.org/PrizedScience and by request on DVD. Prized Science ...

By improving pain treatment, therapy in dogs, research offers medical insight for humans

2012-09-25

MANHATTAN, KAN. -- A Kansas State University professor's research improving post-surgery pain treatment and osteoarthritis therapy in dogs may help develop better ways to treat humans for various medical conditions. From the use of hot and cold packs to new forms of narcotics, James Roush, professor of clinical sciences, is studying ways to lessen pain after surgery and improve care for small animals, particularly dogs. He is working with the clinical patients who come to the College of Veterinary Medicine's Veterinary Health Center. Because humans and dogs experience ...

Grief stages can be likened to pinball machine workings, Baylor University Researcher says

2012-09-25

WACO, Texas (Sept. 25, 2012) — Moving through the traditional stages of grief can be as unpredictable as playing a pinball machine, with triggers of sorrow acting like pinball rudders to send a mourner into a rebound rather than an exit, according to a case study by a Baylor University researcher and a San Antonio psychologist. For some, grieving is complete after the loss is accepted. But for others, such events as the anniversary of a death or a scene that jogs the memory can send them slamming into grief again, according to a case study by Margaret Baier, Ph.D., an ...

Spirituality key to Chinese medicine success

2012-09-25

Are the longevity and vitality of traditional Chinese medicine (TCM) due to its holistic approach? Indeed, Chinese medicine is not simply about treating illness, but rather about taking care of the whole person—body, mind, and spirit. According to an analysis¹ of TCM's origins and development by Lin Shi from Beijing Normal University and Chenguang Zhang from Southwest Minzu University in China, traditional Chinese medicine is profoundly influenced by Chinese philosophy and religion. To date, modern science has been unable to explain the mechanisms behind TCM's effects. ...

Minority children at a higher risk for weight problems in both the US and England

2012-09-25

Los Angeles (September 25, 2012)- With ties to diabetes, hypertension, and high cholesterol, childhood obesity in wealthy countries is certainly of growing concern to researchers. A new study explores the ties between childhood weight problems, socioeconomic status, and nationality and finds that race, ethnicity, and immigrant status are risk factors for weight problems among children in the US and England. This new study was published in the September issue of The ANNALS of the American Academy of Political and Social Science (a SAGE journal) titled "Migrant Youths and ...

Making it easier to make stem cells

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: